Answers are grounded in this paper and cite their sources.
Background Congenital heart disorders (CHD) are structural or functional heart diseases that are present at birth or found later in life. Conotruncal heart defects are one of the most common causes of symptomatic cyanotic cardiac disease. The 22q11.2 deletion syndrome is frequently linked to conotruncal abnormalities with varied presentation. The purpose of this research is to find out more about prevalence of 22q11.2 microdeletion and other genetic abnormalities in patients with conotruncal anomalies and its impact so as to formulate a genetic screening protocol. Primary Objective The main aim of this study was to analyse the frequency of 22q11.2 deletion in syndromic and nonsyndromic conotruncal anomalies. Secondary Objectives The secondary aim of this study was to determine the frequency of karyotypic or chromosomal abnormalities other than 22q11.2 deletion in patients with conotruncal anomalies. This study also aimed to compare the postoperative outcome in 22q11.2 deletion positive and negative cases of conotruncal anomalies. Materials and Methods This study was prospective observational study conducted in the Pediatric Cardiology Department of Star Hospital, Hyderabad, Telangana, India, over a period of two years. Genetics evaluation mainly included multiplex ligation-dependent probe amplification (MLPA) for 22q11.2 microdeletion and Karyotype. SALSA MLPA Probemix P064-C2 microdeletion syndromes-1B was used in this particular study to detect aberrant copy numbers of several chromosomal regions known to cause mental retardation syndromes. Results and Discussion This prospective observational study was conducted from December 2019 to November 2021. During this period, a total of 648 pediatric patients with cardiac anomalies requiring either surgery or intervention were admitted to hospital, of which 74 cases of conotruncal anomalies were included in this study. Median age at admission to hospital was 11 months, median weight was 7.6 kg (interquartile range [IQR]: 6.6–10), and median height/length was 70 cm (IQR: 67–80). Most common conotruncal anomaly in enrolled babies was tetralogy of Fallot (TOF) with good/fair pulmonary artery anatomy found in 30 (40%) cases. Extracardiac malformations were seen in 15 cases (20%). Among clinically syndromic cases, eight cases had abnormal genetic test (10.8%). None of the nonsyndromic cases had an abnormal genetic test. Frequency of 22q11.2 deletion in cases with conotruncal anomalies was 3 in 74 (4%). Frequency of other genetic syndromes was also seen in our study. In this study, there was no statistically significant difference in incidence of postoperative complications, death rate, or mean duration of intensive care unit (ICU) or hospital stay between genetic positive and negative cases. Conclusion Our research is the first population-based study of this magnitude using MLPA instead of fluorescence in situ hybridization (FISH) to examine the frequency of chromosome aberrations in children with conotruncal heart defects, especially 22q11.2 deletion syndrome and their impact on patient himself in terms of immediate outcomes after cardiac surgery, social, economic, and emotional impact on family and finally, on the whole healthcare system involved with the patient care.
No takes yet. Share an insight, caveat, or question.
Uppal et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: